Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Office Of Generic Drugs Gets New Permanent Director And Oversight Designee

Jun 08 2023

• By Brenda Sandburg

Leader — FDA chooses new leader of Generic Drugs Office • Source: Shutterstock

Related Content

Cavazzoni Begins Putting Her Mark On FDA Drug Center With New Principal Deputy Position

Jul 07 2021

FDA’s Generics Office Loses Another Director As Geba Makes Quick Exit

Mar 14 2013

FDA Generics Office Gets Third Director In Three Workdays; Uhl Brings Policy, Pharmacology Experience

Mar 20 2013

Postmarketing Safety Gets Closer Focus In Latest US FDA Drugs Center Reorganization

Jan 08 2021

US FDA’s New Acting Generics Chief Relearning System After 24 Years Of Experience

Nov 04 2022

Next US FDA Generics Leader Must Have ‘Frank Conversations’ With Colleagues, Industry, Former OGD Director Says

Sep 27 2022

One Year On, US FDA Generic Drug Cluster Focuses On Facilitating Collaboration

Aug 08 2022

Additional Topics

United States FDA Generic Drugs Leadership Regulation BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window